Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 435, pseudogene (RN7SL435P)

Target
RN7SL435P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

**RN7SL435P** is a human pseudogene corresponding to the 7SL RNA gene family, formally named "RNA, 7SL, cytoplasmic 435, pseudogene."[6] The 7SL RNA itself is the RNA component of the signal recognition particle (SRP), important for directing nascent secretory and membrane proteins to the endoplasmic reticulum during translation[1][5]. However, RN7SL435P is a **pseudogene**—a DNA sequence similar to a functional gene but rendered non-functional through mutation, truncation, or lack of expression[6][3][7][8]. Most 7SL RNA-like sequences dispersed in the human genome are such pseudogenes and do not give rise to functional RNA molecules, nor are they known to have direct biological, disease, or pharmacological roles; they result from reverse transcription and insertion events involving the original 7SL RNA gene, but lack expression of a functional product[3][7][8][6]. There is no evidence that RN7SL435P encodes a therapeutic target, participates in major biological pathways, or is relevant for biomarker or drug development. **Key points:** - RN7SL435P is a non-coding RNA pseudogene, not an active receptor, enzyme, or protein. - There are hundreds of such 7SL pseudogenes in the human genome, most of which are non-functional and not expressed[3][7][8]. - The canonical functional role belongs to the actual 7SL RNA gene and its product, not the pseudogenes[1][5]. - RN7SL435P is not currently associated with disease or therapeutic targeting. - No drugs, biomarkers, or safety concerns are relevant to this pseudogene.

Other names
7SL RNA pseudogeneRNA, 7SL, Cytoplasmic 435, PseudogeneRN7SL435P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 435, pseudogene (RN7SL435P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 435, pseudogene (RN7SL435P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call